ArticleACS omega2017

Beyond the Antagonism: Self-Labeled Xanthone Inhibitors as Modeled "Two-in-One" Drugs in Cancer Therapy.

Fu-Chao Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.